Allstocks.com's Bulletin Board
Topic Closed  Topic Closed
Post New Topic  New Poll  
Topic Closed  Topic Closed
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » THLD - Threshold Pharmaceutical(NASDAQ)

 - UBBFriend: Email this page to someone!    
Author Topic: THLD - Threshold Pharmaceutical(NASDAQ)
MoMoMoney
Member


Icon 1 posted      Profile for MoMoMoney     Send New Private Message       Edit/Delete Post 
huge drop from $14 to $3 due to FDA news that one of its drugs in trial was toxic to the liver.
This looks like an overaction I believe. Soon this stock will climb back up to $10. Good long term play here.

Posts: 785 | From: la | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
MoMoMoney
Member


Icon 1 posted      Profile for MoMoMoney     Send New Private Message       Edit/Delete Post 
37 million OS

Threshold Pharmaceutical is developing targeted therapeutics for cancer and benign prostatic hyperplasia.

More can be found here.
http://www.thresholdpharm.com/

Posts: 785 | From: la | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
MoMoMoney
Member


Icon 1 posted      Profile for MoMoMoney     Send New Private Message       Edit/Delete Post 
They currently have several clinical trials.

Pancreatic Cancer
TH-CR-302: Phase 3 study of glufosfamide alone for second line treatment of metastatic pancreatic cancer. This trial is currently enrolling men and women with advanced pancreatic cancer in various locations in the US, Latin America, Eastern Europe and Russia.

TH-CR-301: Phase 1/2 study of glufosfamide in combination with gemcitabine in advanced solid tumors or in first line treatment of pancreatic cancer. This trial is currently enrolling men and women with advanced pancreatic cancer into the Phase 2 portion of the study in various locations in the US and Brazil.


Various Cancers
TH-CR-101: Phase 1 study of 2-Deoxyglucose (2DG) in combination with docetaxel in patients with advanced solid tumors. The trial is currently enrolling men and women with a variety of cancers at the UM Sylvester Comprehensive Cancer Center, Miami, FL and the Cancer Therapy and Research Center (CTRC), San Antonio, TX.


Benign Prostatic Hyperplasia (BPH)
TH-CR-203: TH-CR-203 is a Phase 2 study that will evaluate the effectiveness and safety of TH-070 for the treatment of symptomatic Benign Prostatic Hyperplasia (BPH). Approximately 200 patients have been enrolled. The study, which is now closed to enrollment, is being conducted in various locations across the United States.

TH-CR-202: TH-CR-202 is a randomized Phase 3 study that will evaluate the effectiveness and safety of TH-070 (50 mg or 150 mg). Approximately 500 patients have been enrolled. The study, which is now closed to enrollment, is being conducted in various locations across Europe and Canada.

Posts: 785 | From: la | Registered: May 2005  |  IP: Logged | Report this post to a Moderator
Dustoff 1
Member


Rate Member
Icon 1 posted      Profile for Dustoff 1     Send New Private Message       Edit/Delete Post 
Have you had problems with the search feature?
Stock was posted yesterday...Sometimes the search feature can mis-behav. LOL

Posts: 10729 | From: oregon | Registered: Feb 2005  |  IP: Logged | Report this post to a Moderator
   

Post New Topic  New Poll  
Topic Closed  Topic Closed
Open Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share